Topical steroids:

Indications for: HALOG

Corticosteroid-responsive dermatoses.

Adults and Children:

Apply to affected areas 2–3 times daily. Discontinue when control is achieved. Do not occlude.

HALOG Warnings/Precautions:

Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

HALOG Classification:


Adverse Reactions:

Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria; HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia, glucosuria.

How Supplied:

Crm, oint—30g, 60g, 240g

Pricing for HALOG

60g of 0.1% tube of cream (Qty: 1)
Appx. price $365